Results 21 to 30 of about 63,306 (217)

Gemcitabine plus carboplatin versus mitomycin, ifosfamide, and cisplatin in patients with stage IIIB or IV non-small-cell lung cancer: a phase III randomized study of the London Lung Cancer Group [PDF]

, 2005
Purpose: This phase III randomized trial compared two chemotherapy regimens, gemcitabine plus carboplatin and mitomycin, ifosfamide, and cisplatin, in chemotherapy-naive patients with advanced non-small-cell lung cancer (NSCLC).
Harper, P.G., Johnson, P.W.M., Harper, P. G., Qian, W., Rudd, R. M., Spiro, S.G., Gregory, W. M., Hatton, M., Eisen, T. G., James, L.E., Rankin, E. M., Johnson, P. W. M., Rankin, E.M., Spiro, S. G., Rudd, R.M., Lee, S. M., Littler, J. A. H., Lee, S.M., Littler, J.A.H., Eisen, T.G., Martin, W.M.C., Gregory, W.M., James, L. E., Gower, N. H., Martin, W. M. C., Gower, N.H.   +25 more
core   +1 more source

Multimodal kidney‐preserving approach in localised and locally advanced high‐risk upper tract urothelial carcinoma

BJUI Compass, 2022
Objectives Multimodal kidney‐preserving (MKP) strategies may be an option for patients with localised or locally advanced high‐risk upper tract urothelial carcinoma (UTUC) who have a relative contraindication for nephroureterectomy (NU).
Omar Alhalabi, Matthew T. Campbell, Lianchun Xiao, Ana C. Adriazola, Nathaniel R. Wilson, Arlene O. Siefker‐Radtke, Paul G. Corn, Amado Zurita, Eric Jonasch, Jianjun Gao, Mehrad Adibi, Ashish M. Kamat, Neema Navai, Louis L. Pisters, Colin Dinney, Surena F. Matin, Amishi Y. Shah   +16 more
doaj   +1 more source

Phase I study of everolimus and mitomycin C for patients with metastatic esophagogastric adenocarcinoma [PDF]

, 2013
This study aimed at determining the recommended dose of the mammalian target of rapamycin inhibitor everolimus in combination with mitomycin C (MMC) in patients with previously treated metastatic esophagogastric cancer.
Werner, Dominique, Pustowka, Anette, Pauligk, Claudia, Jäger, Elke, Batran, Salah-Eddin al-, Atmaca, Akin   +5 more
core   +1 more source

Real world survival data of a rare malignancy: Anal cancer results in HIV negative patients from Turkey

The Turkish Journal of Gastroenterology, 2018
Background/Aims: An organ preservation approach using chemoradiotherapy has been established for anal cancer. This retrospective cohort study aimed to define the clinico-demographic characteristics and outcomes of cases of human immunodeficiency virus ...
Ece Esin, Ferah Yıldız, Şahin Laçin, Yusuf Karakaş, Melis Gültekin, Şuayib Yalçın   +5 more
doaj   +1 more source

Structure-activity relationships for mitomycin C and mitomycin A analogues

, 1996
A set of 30 mitomycin C and mitomycin A analogues, including 5 new compounds, was screened against 3 different solid human tumor cell lines using the MTT tetrazolium dye assay.
Kunz, Kenneth Robert
core   +4 more sources

Analysis of HepG2 cell response to a wide concentration range of mitomycin C using a multichannel quartz crystal microbalance system with a microscope

Heliyon, 2023
The morphological response of HepG2 cells to mitomycin C was analyzed using a multichannel quartz crystal microbalance system equipped with a home-built movable microscope that enables the simultaneous acquisition of cell images and measurements of eight-
Hiroshi Muramatsu, Masahiro Naka, Sae Ito, Maki Kawamura   +3 more
doaj   +1 more source

Exosomal Long Non-coding RNA HOTTIP Increases Resistance of Colorectal Cancer Cells to Mitomycin via Impairing MiR-214-Mediated Degradation of KPNA3

Frontiers in Cell and Developmental Biology, 2021
It has been reported that long non-coding RNA HOXA distal transcript antisense RNA (lncRNA HOTTIP) functions as a tumor promoter in colorectal cancer (CRC).
Xijuan Chen, Yingqiang Liu, Qinglan Zhang, Baoxing Liu, Yan Cheng, Yonglei Zhang, Yanan Sun, Junqi Liu, Hong Gen   +8 more
doaj   +1 more source

Mitomycin and 5‐fluorouracil for second‐line treatment of metastatic squamous cell carcinomas of the anal canal

Cancer Medicine, 2019
Background Metastatic squamous cell carcinomas (SCC) of the anal canal are rare and there is no international consensus on their second‐line management.
Angélique Saint, Ludovic Evesque, Alexander T. Falk, Gérard Cavaglione, Lucile Montagne, Karen Benezery, Eric Francois   +6 more
doaj   +1 more source

Mitomicina-C como inibidor de sinéquias em meatos médios nas cirurgias sinusais: resultados preliminares The use of Mitomycin-C to reduce synechia in middle meatus in sinus surgery: preliminary results

Brazilian Journal of Otorhinolaryngology, 2012
As sinéquias constituem a complicação pós-operatória mais frequente das cirurgias endoscópicas sinusais, chegando a 36% dos casos. Na tentativa de diminuir esse índice, inúmeros materiais têm sido utilizados, dentre eles a Mitomicina-C (MMC).
Wellington Yugo Yamaoka, Luís Carlos Gregório   +1 more
doaj   +1 more source

Prophage Activation Triggers Extracellular Synthesis of DNA in Bacterial Biofilms via Rolling Circle Replication

Angewandte Chemie, EarlyView.
Shewanella oneidensis and Bacillus subtilis, both harboring prophages, reveal a novel biosynthetic route to scalable and programmable DNA superstructures in flower‐ and wire‐like shapes, respectively. Activation of prophages is achieved via 3‐hour starvation and monitored using reporter strains.
Gabriel Antonio S. Minero, Line Mørkholt Lund, Lasse Hyldgaard Klausen, Obinna Markraphael Ajunwa, Mingdong Dong, Rikke Louise Meyer, Victoria Birkedal, Kai Thormann   +7 more
wiley   +2 more sources